Clinical Guest Contributors

  1. The Rise Of Antimicrobial Resistance And Strategic Research Imperatives For 2026 12/26/2025

    Antimicrobial resistance (AMR) has increasingly worried public health officials and researchers alike in 2025. Now, in 2026, TAXI Pharmaceutical President and CEO Gregory G. Mario, MBA, is calling for more targeted approaches and the integration of AI for quicker discovery and development.

  2. Is Your Team Burnt Out? Discover The ROI Of Healthy Employees Running Trials 12/23/2025

    Clinical trials require attention to detail, but one key variable is often overlooked: the physical, mental, and emotional wellbeing of the people behind the science and operations. How can companies make sure their workforce is ready and able to perform in high-stakes drug development?

  3. 6 Pillars To Support Community Hospitals' First Steps Into Clinical Trials 12/22/2025

    Discover six pillars community hospitals can leverage to make a compelling case for clinical trials: dedicated infrastructure, community engagement, technology platforms, financial support, strategic partnerships, and physician engagement.

  4. Most Ex-U.S. Countries Can't Access The Medicines They Help Study 12/19/2025

    When a country hosts a clinical trial, we assume patients there will eventually benefit from the therapy they helped test. Research Jennifer E. Miller, Ph.D., says that's not often the case.

  5. More Patient Insight — And Funding— Needed To Advance Preeclampsia Research 12/18/2025

    Preeclampsia Foundation’s Laney Poye discusses the urgent need for sustained preeclampsia research funding, patient-informed trial design, and stronger partnerships between advocacy groups and biopharma. 

  6. What Is Win Ratio, And How Can It Be Used In Rare Disease Research? 12/17/2025

    Amber Salzman, CEO of Epicrispr Biotechnologies, explains how applying the win ratio in facioscapulohumeral muscular dystrophy (FSHD) could transform the way researchers evaluate therapeutic impact, enhance statistical efficiency, and improve trial design.

  7. Adaptive Trial Design Is Changing Oncology And Hematology Clinical Trials 12/16/2025

    Pfizer Global Development Lead, Clinical Development Oncology & Hematology, Shreya Badhrinarayanan, MD, explains how adaptive trials, enriched by AI and better data integration, are transforming oncology and hematology clinical research.

  8. Poland: An Underestimated Clinical Trials Powerhouse 12/15/2025

    Poland is not “one of the good options” or “an interesting emerging market," says Tomasz Szelag, head of clinical operations, Ryvu Therapeutics. Rather, it should be one of the first places sponsors look to run their clinical trials.

  9. Can't-Miss Advice On Selecting Your First AI-Enabled Vendor 12/12/2025

    Quarles & Brady's Simone Colgan Dunlap and Meghan O’Connor offer actionable guidance to help sponsor companies make informed, strategic choices in an evolving AI market.

  10. Clinical Supply's Role In Driving Success In Decentralized Trials 12/11/2025

    Decentralized trials are a challenge for supply chain professionals. Explore how logistics, labeling, and home delivery make or break trial outcomes.